Various gene silencing technologies like siRNA, miRNA, ribozymes, DNAzymes have shown promise as therapeutics agents against viral diseases. RNAi-based drugs against viruses such as ebola virus ...
Researchers developed an epigenetic editing approach to silence the PCSK9 gene, achieving long-term cholesterol reduction ...
Using RNA to interfere with a gene’s expression ... that showed a single injection of divalent siRNA led to silencing of the gene that causes Huntington’s. This silencing lasted at least ...
Two years after starting to work together, Novo Nordisk and Dicerna have selected the first candidate from a joint project to find new, gene-silencing ... find multiple RNA interference (RNAi ...
OliX and Eli Lilly announced a global licensing agreement, focusing on the development and commercialization of OliX’s ...
"Mr. Deming's extensive experience in in the biopharma sector, both through his investment banking career and service on a number of corporate boards provides a valuable resource to Phio as we pursue ...
Dicerna Pharma has enticed another big pharma to partner its RNA interference platform, attracting a $200 million upfront deal with Roche for a drug to treat hepatitis B virus infections.